4.950USD+1.85%Mkt Cap: 185.67M $P/E: —1d ago
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internati…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap185.67M $
Enterprise Value364.23M $
Revenue (TTM)129.46M $
Gross Profit40.30M $
Net Income (TTM)-38.72M $
Revenue/Share3.464 USD
Last Price4.950 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees382
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.11
PEG2.66
EV/EBITDA44.19
EV/Revenue2.81
P/S1.43
P/B-6.52
EPS (TTM)-1.27
EPS (Forward)-0.81
52W Range
3.63025% of range8.980
52W High8.980 USD
52W Low3.630 USD
Profitability
Gross Margin31.27%
Oper. Margin-13.25%
EBITDA Margin6.37%
Profit Margin-30.04%
ROE272.62%
ROA-16.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-206.00K $
CapEx (TTM)13.41M $
FCF Margin—
FCF Yield—
Net Debt129.35M $
Net Debt/EBITDA15.69
Balance Sheet
Debt/Equity-10.04
Current Ratio3.49
Quick Ratio2.18
Book Value/Sh-0.7590 USD
Cash/Share0.5540 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.833 USD
Upside (mean)+38.0%
Target Range5.000 USD – 9.000 USD
$5.000+38.0% to mean$9.000
# Analysts3
Ownership
Shares Out.37.51M
Float19.43M
Insiders2.83%
Institutions77.24%
Short Interest
Short Ratio9.6d
Short % Float7.82%
Short % Out.6.36%
Shares Short2.38M
Short (prev mo.)2.35M
Technical
SMA 505.077 (-2.5%)
SMA 2006.385 (-22.5%)
Beta1.06
S&P 52W Chg20.25%
Avg Vol (30d)215.66K
Avg Vol (10d)170.26K
Technical Indicators
RSI (14)46.2
MACD-0.1355
MACD Signal-0.0848
MACD Hist.-0.0507
BB Upper5.857 USD
BB Middle5.149 USD
BB Lower4.442 USD
BB Width27.48%
ATR (14)0.2957 USD
Vol Ratio (20d)1.06x